Navigation Links
Pharmos Corporation Announces Board and Management Changes
Date:1/3/2008

yte), ExSAR and Targent.

Mr. Johnston served as CEO of Cytogen from July 1988 to April 1989. He is also a member of the Advisory Council of the Department of Molecular Biology at Princeton University and the Executive Committee of the Friends of the Institute for Advanced Study in Princeton, as well as Founder and President of Educational Ventures, a foundation focused on funding improvements in the educational system; and Vice-Chairman of Center for Education Reform (CER) an advocate for charter schools. Mr. Johnston received his B.A. from Princeton University and his M.B.A. from New York University.

S. Colin Neill

S. Colin Neill who becomes President of the Company, became Senior Vice President, Chief Financial Officer, Secretary and Treasurer of Pharmos in October 2006. From September 2003 to October 2006, Mr. Neill served as Chief Financial Officer, Treasurer and Secretary of Axonyx, Inc. a biopharmaceutical company that developed products and technologies to treat Alzheimer's disease and other central nervous system disorders, where he played an integral role in the merger between Axonyx and TorreyPines Therapeutics Inc., a privately- held biopharmaceutical company. From 1998 to 2001, Mr. Neill served as Senior Vice President, Chief Financial Officer, Secretary and Treasurer of ClinTrials Research Inc., a $100 million publicly traded global contract research organization in the drug development business. Mr. Neill played a key role in the successful sale of the company in 2001. Mr. Neill graduated from Trinity College, Dublin with a first class honors degree in Business / Economics and he holds a masters degree in Accounting and Finance from the London School of Economics. He is a Certified Public Accountant in New York State and a Chartered Accountant in Ireland.

About Pharmos Corporation

Pharmos Corporation is a biopharmaceutical company that discovers and develops novel therapeutics to treat a range of diseases of the nervo
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
2. Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
3. Pharmos Corporation Reports 2007 Third Quarter Results
4. Pharmos Issues Letter to Shareholders
5. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
6. CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
7. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
10. FMC Corporation and Pronova BioPharma Announce Agreement To Develop New Alginate-Based Capsule Products
11. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall...thatRandyScott,GenomicHealth,sExecutiveChairman,wi...erenceinNewYorkCityonTuesday,December1,2009at10:00...edwebcastofthepresentation,visittheInvestorRelatio...r.genomichealth.com .Pleaseconnecttothewebsiteatle...
(Date:11/24/2009)... Program Connects Customers w...les Collected with DNA Genotek Products , ...009 -- DNA Genotek , a leading provider of produc... and preparation, today announced its new global p...ancements for DNA Genotek,s partner community and ...
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellTher...lpresentatthe21stAnnualPiperJaffrayHealthCareConfe...eNewYorkPalaceHotel. ,, CTIwillpresentonTuesday...).AliveaudiowebcastofCTI,spresentationwillbeavaila...ilableforreplayafterwards. , ,PiperJaffrayHealthC...
(Date:11/23/2009)...AMPAIGN, Ill. You can think of it as origami ver...ity of Illinois have developed a technique for fab...icon structures from thin films by coupling photol...pillary interactions. , The films, only a few mic...ot possible with thicker pieces of the same materi...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2
...rformance-based management. Like other vacuous ter...customer-centric, value added, and mission critica...adictory meanings. , ,In practice, performance-ba...what I call management by 2x4 variations of the a... to get them to do what they are supposed to be do...
...our choice! , ,So what does government have to d...ean government -- I meant governance ! Ther... governance. You could say that government caused ... governance. The considerable number of scandals i...e reduced the publics trust in business. In 2002, ...
...of the most volatile mixtures available to modern ...orse, weve learned that randomly throwing matches ...ely, many organizations seem to have translated th...combination of strategy and technology. Handle the... to serve the strategy, and always in that order. ...
Other Biology Technology:The myth of the performance-based management 2The myth of the performance-based management 3Part 4 Project Performance Get on the path to continuous improvement 2Part 4 Project Performance Get on the path to continuous improvement 3Strategy and technology 2
(Date:11/24/2009)...ibed by traditional healers in Brazil to treat a r...o fever and flu. , Now for the first time, resear...ientifically prove the pain relieving properties o...int. , Testing this ancient South American herb o...was able to show that when prepared as a ,tea, th...
(Date:11/24/2009)...ries from collapsing have been true life-savers. B...eded -- once the arteries are strengthened, they b...ce but to leave them in place. , Prof. Meital Zi...medical Engineering has developed a new patent-pen...re needed, then dissolves. , "Our new composite ...
(Date:11/24/2009)...ecrets of the earth,s history locked in its icy de...le information on the environments that have been ... Now, a team of researchers from nine institutions...10 million dollars by the National Science Foundat...ally. These scientists will drill through the West...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2LSU gets to the bottom of things -- in Antarctica 2PDL BioPharma Announces Record Date for October 1 Dividend Payment 48432 1RetireSafe Blasts Plan to Pay for Health Care Reform With Huge Medicare Cuts 48429 1RetireSafe Blasts Plan to Pay for Health Care Reform With Huge Medicare Cuts 48429 2EyeIC Receives FDA 510 28k 29 Clearance for MatchedFlicker 28TM 29 Retinal Aid Detection Technology 12560 1EyeIC Receives FDA 510 28k 29 Clearance for MatchedFlicker 28TM 29 Retinal Aid Detection Technology 12560 2EyeIC Receives FDA 510 28k 29 Clearance for MatchedFlicker 28TM 29 Retinal Aid Detection Technology 12560 3
...costs due to complications from preterm birth are ...e of surviving preterm infants are estimated to be...ed, placebo-controlled clinical study, researchers...d entered premature labor led to significant impro...study are reported in the January issue of the Ame...
...ges in growth rates in some coastal and long-lived... are consistent with shifts in wind systems and wa...arch published in the United States this week. , “...ish species related to their environmental conditi...metres and slower rates of growth below 1,000 metr...
... cancers arise due to defects in genes that normal... MIT researchers have shown that re-activating one... or disappear. , The study offers evidence that t... for human cancer drugs. , "If we can find drug...ch this pathway is blocked, they may be effective ...
Other Biology News:Fish growth changes enhanced by climate change 2Reactivated gene shrinks tumors 2Reactivated gene shrinks tumors 3
Feature Extraction Software; 1-year License for Not-For-Profit/Academic from Agilent Technologies
...vides a unique signal amplification technology to ...uding cell-surface receptors and subcellular struc...s the patented ELF 97 phosphatase substrate, which...itate at the site of enzymatic activity a process...
...mmercial and lab-prepared glass arrays. The type o...he attached nucleic acid targets, and the manufact...hybridization conditions for glass microarray anal...r, it is impossible for one hybridization buffer p...
... combo offers these benefits: Saves money ver...ers a safer and better alternative to ethidium bro...nment and your institution Agarose resolves DNA an...garose is a standard melting temperature, multi-pu...
Biology Products: